CoreFirst Bank & Trust’s GSK GSK Stock Holding History

CoreFirst Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.1K	Hold	472	–	–	0.01%	235
2025 Q4	$23.1K	Sell	472 -400	-46%	-$18.7K	0.01%	241
2025 Q3	$37.6K	Hold	872	–	–	0.02%	226
2025 Q2	$33.5K	Buy	+872	New	+$33.3K	0.02%	237
2025 Q1	–	Sell	-1,752	Closed	-$59.3K	–	202
2024 Q4	$59.3K	Hold	1,752	–	–	0.04%	203
2024 Q3	$71.6K	Buy	+1,752	New	+$71.7K	0.04%	190
2024 Q2	–	Sell	-1,752	Closed	-$75.1K	–	214
2024 Q1	$75.1K	Sell	1,752 -160	-8%	-$6.6K	0.05%	189
2023 Q4	$70.9K	Hold	1,912	–	–	0.05%	195
2023 Q3	$69.3K	Hold	1,912	–	–	0.05%	204
2023 Q2	$68.1K	Sell	1,912 -224	-10%	-$8.04K	0.05%	200
2023 Q1	$76K	Sell	2,136 -920	-30%	-$32.2K	0.06%	186
2022 Q4	$107K	Buy	+3,056	New	+$102K	0.08%	177
2022 Q3	–	Sell	-4,657	Closed	-$253K	–	397
2022 Q2	$253K	Hold	4,657	–	–	0.2%	110
2022 Q1	$254K	Hold	4,657	–	–	0.17%	116
2021 Q4	$257K	Hold	4,657	–	–	0.17%	118
2021 Q3	$222K	Hold	4,657	–	–	0.15%	126
2021 Q2	$232K	Hold	4,657	–	–	0.16%	126
2021 Q1	$208K	Hold	4,657	–	–	0.14%	131
2020 Q4	$214K	Buy	+4,657	New	+$214K	0.16%	120

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CoreFirst Bank & Trust's GSK Position: Q1 2026 in Review

CoreFirst Bank & Trust held its GSK (GSK) position steady in Q1 2026 at 472 shares worth $26.1K. The position accounts for 0.01% of the portfolio, ranked #235.

CoreFirst Bank & Trust first reported a position in GSK in Q4 2020 and has held it in 19 quarters since. The position peaked at $257K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

CoreFirst Bank & Trust held 472 shares of GSK worth $26.1K as of Q1 2026.
CoreFirst Bank & Trust left its GSK share count unchanged in Q1 2026.
GSK made up 0.01% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #235 holding.
CoreFirst Bank & Trust first reported a position in GSK in Q4 2020 and has held it in 19 quarters since.
CoreFirst Bank & Trust's GSK position peaked at $257K in Q4 2021.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.